List of Tables
Table 1. Biologics and Biosimilars Market Trends
Table 2. Biologics and Biosimilars Market Drivers & Opportunity
Table 3. Biologics and Biosimilars Market Challenges
Table 4. Biologics and Biosimilars Market Restraints
Table 5. Global Biologics and Biosimilars Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Biologics and Biosimilars Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Biologics and Biosimilars Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Biologics and Biosimilars Product Type
Table 9. Key Companies Time to Begin Mass Production of Biologics and Biosimilars
Table 10. Global Biologics and Biosimilars Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Biologics and Biosimilars Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Biologics and Biosimilars Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Biologics and Biosimilars Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Biologics and Biosimilars Sales Market Share in Value by Type (2020-2025)
Table 17. Global Biologics and Biosimilars Sales Market Share in Value by Type (2026-2031)
Table 18. Global Biologics and Biosimilars Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Biologics and Biosimilars Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Biologics and Biosimilars Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Biologics and Biosimilars Sales Market Share in Value by Application (2020-2025)
Table 22. Global Biologics and Biosimilars Sales Market Share in Value by Application (2026-2031)
Table 23. Global Biologics and Biosimilars Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Biologics and Biosimilars Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Biologics and Biosimilars Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Biologics and Biosimilars Sales Value by Region (2020-2025) & (%)
Table 27. Global Biologics and Biosimilars Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Biologics and Biosimilars Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Biologics and Biosimilars Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Biologics and Biosimilars Sales Value, (2026-2031) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Biologics and Biosimilars Products, Services and Solutions
Table 34. Revenue (US$ Million) in Biologics and Biosimilars Business of Roche (2020-2025)
Table 35. Roche Recent Developments
Table 36. Amgen Basic Information List
Table 37. Amgen Description and Business Overview
Table 38. Amgen Biologics and Biosimilars Products, Services and Solutions
Table 39. Revenue (US$ Million) in Biologics and Biosimilars Business of Amgen (2020-2025)
Table 40. Amgen Recent Developments
Table 41. AbbVie Basic Information List
Table 42. AbbVie Description and Business Overview
Table 43. AbbVie Biologics and Biosimilars Products, Services and Solutions
Table 44. Revenue (US$ Million) in Biologics and Biosimilars Business of AbbVie (2020-2025)
Table 45. AbbVie Recent Developments
Table 46. Sanofi Basic Information List
Table 47. Sanofi Description and Business Overview
Table 48. Sanofi Biologics and Biosimilars Products, Services and Solutions
Table 49. Revenue (US$ Million) in Biologics and Biosimilars Business of Sanofi (2020-2025)
Table 50. Sanofi Recent Developments
Table 51. Johnson & Johnson Basic Information List
Table 52. Johnson & Johnson Description and Business Overview
Table 53. Johnson & Johnson Biologics and Biosimilars Products, Services and Solutions
Table 54. Revenue (US$ Million) in Biologics and Biosimilars Business of Johnson & Johnson (2020-2025)
Table 55. Johnson & Johnson Recent Developments
Table 56. Pfizer Basic Information List
Table 57. Pfizer Description and Business Overview
Table 58. Pfizer Biologics and Biosimilars Products, Services and Solutions
Table 59. Revenue (US$ Million) in Biologics and Biosimilars Business of Pfizer (2020-2025)
Table 60. Pfizer Recent Developments
Table 61. Novo Nordisk Basic Information List
Table 62. Novo Nordisk Description and Business Overview
Table 63. Novo Nordisk Biologics and Biosimilars Products, Services and Solutions
Table 64. Revenue (US$ Million) in Biologics and Biosimilars Business of Novo Nordisk (2020-2025)
Table 65. Novo Nordisk Recent Developments
Table 66. Eli Lilly Basic Information List
Table 67. Eli Lilly Description and Business Overview
Table 68. Eli Lilly Biologics and Biosimilars Products, Services and Solutions
Table 69. Revenue (US$ Million) in Biologics and Biosimilars Business of Eli Lilly (2020-2025)
Table 70. Eli Lilly Recent Developments
Table 71. Novartis Basic Information List
Table 72. Novartis Description and Business Overview
Table 73. Novartis Biologics and Biosimilars Products, Services and Solutions
Table 74. Revenue (US$ Million) in Biologics and Biosimilars Business of Novartis (2020-2025)
Table 75. Novartis Recent Developments
Table 76. Merck Basic Information List
Table 77. Merck Description and Business Overview
Table 78. Merck Biologics and Biosimilars Products, Services and Solutions
Table 79. Revenue (US$ Million) in Biologics and Biosimilars Business of Merck (2020-2025)
Table 80. Merck Recent Developments
Table 81. Biogen Basic Information List
Table 82. Biogen Description and Business Overview
Table 83. Biogen Biologics and Biosimilars Products, Services and Solutions
Table 84. Revenue (US$ Million) in Biologics and Biosimilars Business of Biogen (2020-2025)
Table 85. Biogen Recent Developments
Table 86. Celltrion Basic Information List
Table 87. Celltrion Description and Business Overview
Table 88. Celltrion Biologics and Biosimilars Products, Services and Solutions
Table 89. Revenue (US$ Million) in Biologics and Biosimilars Business of Celltrion (2020-2025)
Table 90. Celltrion Recent Developments
Table 91. Sobi Basic Information List
Table 92. Sobi Description and Business Overview
Table 93. Sobi Biologics and Biosimilars Products, Services and Solutions
Table 94. Revenue (US$ Million) in Biologics and Biosimilars Business of Sobi (2020-2025)
Table 95. Sobi Recent Developments
Table 96. 3SBIO Basic Information List
Table 97. 3SBIO Description and Business Overview
Table 98. 3SBIO Biologics and Biosimilars Products, Services and Solutions
Table 99. Revenue (US$ Million) in Biologics and Biosimilars Business of 3SBIO (2020-2025)
Table 100. 3SBIO Recent Developments
Table 101. Changchun High Tech Basic Information List
Table 102. Changchun High Tech Description and Business Overview
Table 103. Changchun High Tech Biologics and Biosimilars Products, Services and Solutions
Table 104. Revenue (US$ Million) in Biologics and Biosimilars Business of Changchun High Tech (2020-2025)
Table 105. Changchun High Tech Recent Developments
Table 106. Kanghong Pharma Basic Information List
Table 107. Kanghong Pharma Description and Business Overview
Table 108. Kanghong Pharma Biologics and Biosimilars Products, Services and Solutions
Table 109. Revenue (US$ Million) in Biologics and Biosimilars Business of Kanghong Pharma (2020-2025)
Table 110. Kanghong Pharma Recent Developments
Table 111. Innovent Biologics Basic Information List
Table 112. Innovent Biologics Description and Business Overview
Table 113. Innovent Biologics Biologics and Biosimilars Products, Services and Solutions
Table 114. Revenue (US$ Million) in Biologics and Biosimilars Business of Innovent Biologics (2020-2025)
Table 115. Innovent Biologics Recent Developments
Table 116. Gan&Lee Basic Information List
Table 117. Gan&Lee Description and Business Overview
Table 118. Gan&Lee Biologics and Biosimilars Products, Services and Solutions
Table 119. Revenue (US$ Million) in Biologics and Biosimilars Business of Gan&Lee (2020-2025)
Table 120. Gan&Lee Recent Developments
Table 121. Tonghua Dongbao Basic Information List
Table 122. Tonghua Dongbao Description and Business Overview
Table 123. Tonghua Dongbao Biologics and Biosimilars Products, Services and Solutions
Table 124. Revenue (US$ Million) in Biologics and Biosimilars Business of Tonghua Dongbao (2020-2025)
Table 125. Tonghua Dongbao Recent Developments
Table 126. United Laboratory Basic Information List
Table 127. United Laboratory Description and Business Overview
Table 128. United Laboratory Biologics and Biosimilars Products, Services and Solutions
Table 129. Revenue (US$ Million) in Biologics and Biosimilars Business of United Laboratory (2020-2025)
Table 130. United Laboratory Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Biologics and Biosimilars Downstream Customers
Table 134. Biologics and Biosimilars Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Biologics and Biosimilars Product Picture
Figure 2. Global Biologics and Biosimilars Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Biologics and Biosimilars Sales Value (2020-2031) & (US$ Million)
Figure 4. Biologics and Biosimilars Report Years Considered
Figure 5. Global Biologics and Biosimilars Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Biologics and Biosimilars Revenue in 2024
Figure 7. Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Monoclonal Antibodies Picture
Figure 9. Interferon Picture
Figure 10. Insulin Picture
Figure 11. Vaccines Picture
Figure 12. Others Picture
Figure 13. Global Biologics and Biosimilars Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Biologics and Biosimilars Sales Value Market Share by Type, 2024 & 2031
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Retail Pharmacy
Figure 17. Product Picture of Other
Figure 18. Global Biologics and Biosimilars Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 19. Global Biologics and Biosimilars Sales Value Market Share by Application, 2024 & 2031
Figure 20. North America Biologics and Biosimilars Sales Value (2020-2031) & (US$ Million)
Figure 21. North America Biologics and Biosimilars Sales Value by Country (%), 2024 VS 2031
Figure 22. Europe Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 23. Europe Biologics and Biosimilars Sales Value by Country (%), 2024 VS 2031
Figure 24. Asia Pacific Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 25. Asia Pacific Biologics and Biosimilars Sales Value by Region (%), 2024 VS 2031
Figure 26. South America Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 27. South America Biologics and Biosimilars Sales Value by Country (%), 2024 VS 2031
Figure 28. Middle East & Africa Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 29. Middle East & Africa Biologics and Biosimilars Sales Value by Country (%), 2024 VS 2031
Figure 30. Key Countries/Regions Biologics and Biosimilars Sales Value (%), (2020-2031)
Figure 31. United States Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 32. United States Biologics and Biosimilars Sales Value by Type (%), 2024 VS 2031
Figure 33. United States Biologics and Biosimilars Sales Value by Application (%), 2024 VS 2031
Figure 34. Europe Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe Biologics and Biosimilars Sales Value by Type (%), 2024 VS 2031
Figure 36. Europe Biologics and Biosimilars Sales Value by Application (%), 2024 VS 2031
Figure 37. China Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 38. China Biologics and Biosimilars Sales Value by Type (%), 2024 VS 2031
Figure 39. China Biologics and Biosimilars Sales Value by Application (%), 2024 VS 2031
Figure 40. Japan Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 41. Japan Biologics and Biosimilars Sales Value by Type (%), 2024 VS 2031
Figure 42. Japan Biologics and Biosimilars Sales Value by Application (%), 2024 VS 2031
Figure 43. South Korea Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 44. South Korea Biologics and Biosimilars Sales Value by Type (%), 2024 VS 2031
Figure 45. South Korea Biologics and Biosimilars Sales Value by Application (%), 2024 VS 2031
Figure 46. Southeast Asia Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Biologics and Biosimilars Sales Value by Type (%), 2024 VS 2031
Figure 48. Southeast Asia Biologics and Biosimilars Sales Value by Application (%), 2024 VS 2031
Figure 49. India Biologics and Biosimilars Sales Value, (2020-2031) & (US$ Million)
Figure 50. India Biologics and Biosimilars Sales Value by Type (%), 2024 VS 2031
Figure 51. India Biologics and Biosimilars Sales Value by Application (%), 2024 VS 2031
Figure 52. Biologics and Biosimilars Industrial Chain
Figure 53. Biologics and Biosimilars Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
